Olokizumab (CDP 6038) is a humanized monoclonal antibody that targets interleukin-6 (IL-6). Olokizumab inhibits IL-6-induced STAT-3 phosphorylation. Olokizumab is used in the study of arthritis[1][2][3].
Molecular Weight:
(145.94 kDa)
Purity:
99.54
CAS Number:
[1007223-17-7]
Target:
Interleukin Related,STAT
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted